Finance · Search · Sign in · Sign up

Tess buys IBB 266.02: Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary


IBB in Focus This fund provides exposure to 123 firms by tracking the Nasdaq Biotechnology Index with Vertex taking up the eight position at 3.49%. Growth stocks are once again a big part of the portfolio with 86% of assets while large caps account for 58% ... ...


55 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home